ARKVAX LIMITED

Active London

Research and experimental development on biotechnology

5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

ARKVAX LIMITED

Research and experimental development on biotechnology

Founded 22 Oct 2020 Active London, United Kingdom 5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 23 Dec 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 6 Jan 2026 Next due 27 Nov 2026 6 months remaining
Net assets £113K £245K 2024 year on year
Total assets £955K £831K 2024 year on year
Total Liabilities £842K £586K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

London School Of Hygiene And Tropical Medicine Keppel Street London WC1E 7HT

Website

www.example.com

Full company profile for ARKVAX LIMITED (12966888), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 22 Oct 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£935.95k

Increased by £818.55k (+697%)

Net Assets

£113.07k

Increased by £245.42k (+185%)

Total Liabilities

£842.36k

Increased by £585.59k (+228%)

Turnover

N/A

Employees

5

Decreased by 1 (-17%)

Debt Ratio

88%

Decreased by 118 (-57%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (4)

Investor NameInvestor SinceParticipating Rounds
Investor 1Dec 2022Seed
Investor 2Dec 2022Seed
Investor 3Dec 2022Seed

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 525,305 Shares £0.525 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
22 May 2025141,565£0.142£0
29 Nov 2022383,740£0.384£0

Officers

Officers

2 active 1 resigned
Status
Jon CuccuiDirectorItalianEngland4822 Oct 2020Active
Nazira Simin AmraDirectorFrenchEngland5329 Nov 2022Active

Shareholders

Shareholders (12)

Jon Cuccui
32.8%
500,000
Brendan Wren
25.7%
391,667

Persons with Significant Control

Persons with Significant Control (2)

2 Active 1 Ceased

Jon Cuccui

Italian

Active
Notified 22 Oct 2020
Residence England
DOB April 1978
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent
Active
Notified 27 Dec 2023
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Professor Brendan William Wren

Ceased 27 Dec 2023

Ceased

Group Structure

Group Structure

ARKVAX LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
6 Jan 2026Confirmation StatementConfirmation statement made on 13 Nov 2025 with updates
27 Dec 2025Persons With Significant ControlChange to Dr Jon Cuccui as a person with significant control on 27 Dec 2023
23 Dec 2025Persons With Significant ControlCessation of Chariot Innovations Limited as a person with significant control on 22 May 2025
23 Dec 2025AccountsAnnual accounts made up to 31 Oct 2025
2 Dec 2025OfficersChange to director Dr Jolyon Nicolas Edouard Martin on 1 Dec 2025
6 Jan 2026 Confirmation Statement

Confirmation statement made on 13 Nov 2025 with updates

27 Dec 2025 Persons With Significant Control

Change to Dr Jon Cuccui as a person with significant control on 27 Dec 2023

23 Dec 2025 Persons With Significant Control

Cessation of Chariot Innovations Limited as a person with significant control on 22 May 2025

23 Dec 2025 Accounts

Annual accounts made up to 31 Oct 2025

2 Dec 2025 Officers

Change to director Dr Jolyon Nicolas Edouard Martin on 1 Dec 2025

Recent Activity

Latest Activity

Confirmation statement made on 13 Nov 2025 with updates

4 months ago on 6 Jan 2026

Change to Dr Jon Cuccui as a person with significant control on 27 Dec 2023

4 months ago on 27 Dec 2025

Cessation of Chariot Innovations Limited as a person with significant control on 22 May 2025

4 months ago on 23 Dec 2025

Annual accounts made up to 31 Oct 2025

4 months ago on 23 Dec 2025

Change to director Dr Jolyon Nicolas Edouard Martin on 1 Dec 2025

5 months ago on 2 Dec 2025